Editorial, J Aging Geriatr Med Vol: 8 Issue: 3
Frailty: A Comprehensive Review of an Emerging Geriatric Syndrome
Dr. Arun R. Menon*
Department of Geriatric Medicine, India
- *Corresponding Author:
- Dr. Arun R. Menon
Department of Geriatric Medicine, India
E-mail: arunrmenon@gmri.in
Received: 01-May-2025, Manuscript No. agm-25-176131; Editor assigned: 3-May-2025, Pre-QC No. agm-25-176131 (PQ); Reviewed: 17-May-2025, QC No. agm-25-176131; Revised: 24-May-2025, Manuscript No. agm-25- 176131 (R); Published: 31-May-2025, DOI: 10.4172/2576-3946.1000190
Citation: Arun RM (2025) Frailty: A Comprehensive Review of an Emerging Geriatric Syndrome. J Aging Geriatr Med 8: 190
Introduction
Frailty has emerged as one of the most significant clinical challenges in geriatric medicine. As global populations continue to age, the prevalence of frailty is rising, affecting nearly 10â??20 percent of community-dwelling older adults and even more within hospital and long-term care settings [1,2]. Frailty is typically defined as a state of increased vulnerability resulting from cumulative age-related declines in multiple physiological systems. This decline reduces the bodyâ??s ability to maintain homeostasis when exposed to stress [3,4].
Two major conceptual models have shaped our understanding of frailty. The first, known as the Frailty Phenotype introduced by Fried and colleagues, views frailty as a physical syndrome marked by weakness, unintentional weight loss, exhaustion, slow gait speed, and low physical activity. The second, the Frailty Index, considers frailty as the accumulation of health deficits, including diseases, symptoms, disabilities, and laboratory abnormalities.
Risk factors for frailty include advanced age, chronic illnesses, polypharmacy, malnutrition, reduced physical activity, cognitive impairment, and social isolation. Sarcopenia, the age-related loss of muscle mass and strength, plays a central role in the development of frailty. Understanding these risk factors is crucial for implementing early preventive strategies [5].
Frailty is associated with numerous adverse outcomes. Frail older adults are more likely to experience falls, fractures, functional decline, hospitalization, and institutionalization. Moreover, frailty is a strong predictor of mortality independent of chronological age. These consequences highlight the importance of systematic frailty screening in clinical practice.
Management of frailty requires a multidisciplinary approach involving physical exercise programs, nutritional interventions, medication review, cognitive support, and social engagement. Resistance and balance training remain the most effective interventions to improve strength and mobility. Nutritional supplementation, especially protein and vitamin D, further enhances outcomes. Addressing social determinants, such as loneliness and lack of support, is equally essential for holistic care.
Conclusion
Frailty is a prevalent and impactful geriatric syndrome that significantly influences health outcomes in older adults. Early identification and comprehensive management can reduce the risk of disability, hospitalization, and mortality. As the aging population grows, incorporating frailty assessment into routine clinical practice becomes essential. A combination of physical activity, nutritional optimization, medication management, and social support has proven effective in improving resilience and quality of life. Continued research and education are needed to enhance frailty care and promote healthy aging worldwide.
References
- Praveen Kumar (2012) A stability indicating RP-HPLC method development for determination of Ezetimibe in tablet dosage form. Der Pharma Chemica 4: 1296-1304.
- Raul (2015) RP-HPLC Method Development and Validation for the Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form. Asian J Pharm Clin Res 8: 178-181.
- El-Bagary (2014) LC-MS-MS Simultaneous Determination of Atorvastatin and Ezetimibe in Human Plasma. Journal of Chromatographic Science 52:773-780.
- Suneela D, Dhaneshwar S, Deshpande P, Patil M (2007) Development and validation of a method for simultaneous densitometric estimation of Atorvastatin calcium and Ezetimibe as the bulk drug and in tablet dosage forms. Acta Chromatographica 19: 141-148.
- Danafar H (2016) High performance liquid chromatographic method for determination of Ezetimibe in pharmaceutical formulation tablets. Pharmaceutical and Biomedical Research 2: 38-46.
Spanish
Chinese
Russian
German
French
Japanese
Portuguese
Hindi 